Appointment of Broker

RNS Number : 7802Y

Circassia Pharmaceuticals Plc

19 May 2016

 

For immediate release

Circassia Pharmaceuticals plc

Appointment of Broker

19 May 2016

Circassia Pharmaceuticals plc (LSE: CIR) announces that it has appointed Numis Securities Limited as joint broker to the Company, alongside JP Morgan Cazenove, with immediate effect.

- Ends -

Enquiries

Circassia Steve Harris, Chief Executive Officer Julien Cotta, Chief Financial Officer Rob Budge, Corporate Communications	Tel: [phone]
Numis Securities Clare Terlouw / Michael Meade	Tel: [phone]
JP Morgan Cazenove James Mitford / James Deal	Tel: [phone]
FTI Consulting Ben Atwell / Simon Conway / Mo Noonan	Tel: [phone]

 

END

 

 

APPUKUSRNVAVAAR